RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 18, 2016 3:22 EDT

Xicepta Sciences, Inc. manufactures and markets a new generation of wellness products derived from molecular and embryonic materials

iCrowdNewswire - Aug 18, 2016

Xicepta Sciences, Inc. Logo

Xicepta Sciences, Inc.

Belmont, CA 94002, US

Xicepta Sciences, Inc. manufactures and markets a new generation of wellness products derived from molecular and embryonic materials. Our science-based products are cutting-edge and include unique, patent-able ingredients for regenerative and rejuvenation. All of our products are designed by our founder who is an MD and Molecular Biologist.

Our product lines include supplement for cognitive vitality, for heart health, joints and tendon function, for pain management and weight loss management among others.

We launched our first products in June of 2014 after having built, equipped and staffed our own lab and development facility. We’ve sold nearly $10k worth of product in our initial launch and we project nearly $4m in sales during our first year.

Products / Services

Natural wellness supplements

Xicepta manufactures and produces the most advanced molecular wellness supplements available today. Xicepta’s patentable products are unmatched in the market; it uses all-natural ingredients that include Stem Cell Oligopeptide imported from Europe. This Oligopeptide is a human biosimilar (meaning compatible), and the products promote cellular regeneration and rejuvenation. Xicepta’s Oligopeptide is harvested from vaccine grade laboratory chicken egg embryos containing Nerve Growth Factor (NGF), Epidermal Growth Factor (EGF), Connective Tissue Growth Factor (CTF), and Transforming Beta Factor (TBF), all molecular promoters of regeneration and rejuvenation. Combined with binary partners that act as axis of communication to target areas, Xicepta’s supplements effectively produce specific results separating Xicepta from the rest of the market. Other supplements touting the use of stem cell are actually using less effective plant or fruit stem cells.



Chief Executive Officer
John Hayden

Dr. John S. Hayden, co-founder of Xicepta, MD degree, a PhD in Molecular Biology and PhD in Mathematical Medicine. Dr. Hayden was a Federal medical scientist and classified research program director since 1997. In 1998 at Los Alamos National Laboratory, Dr. Hayden developed original research into the mathematical modeling of the Staphylococcal Protein A, and development of a vaccine.

Dr. Hayden was instrumental in advancing the science and technology of human performance. He developed a new generation of Nootropics for physical and mental enhancement in aerospace medicine and space flights. Dr. Hayden’s unique approach to the use of Amino Acids was used by members of NASA STS-96, the second International Space Station Flight in 1999. Dr. Hayden’s catalog of publications is currently classified and not available for public review.

Dr. Hayden currently serves as the CEO and Chief Technology Officer of Xicepta.

President Sales & Marketing
Soledad Manaay

Soledad M. Manaay, President and Co-founder, holds a PhD in International Psychology with focus in Industrial and Organizational Psychology. Dr. Manaay has extensive background in business development, management, public relations, and in strategic sales and marketing. She arrived in the US via the diplomatic service serving as a media attaché. After she resigned from the foreign service she went on to become a successful entrepreneur having owned and managed a high-end boutique in Hawaii and co-publisher of a community newspaper that is now the longest-running paper of its kind in Hawaii. She also served as a real estate principal broker from 2001 to 2009 while working as PR Consultant. Most recently she owned and operated Care On Call, Inc., a home care agency with over 200 employees serving affluent clients in the San Francisco bay area. She sold her company in November 2013. Soledad is also a published author having written and published two books for young adults.

Consulting Advisor
Skip Sanzeri

Mr. Sanzeri has a long history of company operations starting his career in 1986 with the technology division of Ziff-Davis publishing, IAC. Skip spent nine years with Ziff starting as a telemarketer and leaving as a sales director, helping to grow a division from $25 million to over $250 million before selling the Division to Thompson publishing. Being entrepreneurial, Skip also owned and operated a chain of health clubs in the San Francisco Bay Area starting as Golds Gyms, and ending as California athletic clubs before he sold the chain to 24 hour fitness. Skip realized the Internet and its potential and joined Sequoia backed Quote.com as VP of business development. At Quote.com, Skip helped develop some of the first web advertising and sponsorship models and sold the company to Lycos. Skip graduated Claremont McKenna College in 1983 with a degree in economics, and went on to get an MPA from the College of Notre Dame in 1985.


Prior Year Revenue Current Year Revenue Next Year Revenue


Company Age Employees Sub-Industry
3 years 8 Other Pharmaceuticals


Company Type Stock Exchange Stock Symbol
Contact Information:

Skip Sanzeri

View Related News >